Company intelligence / Profile preview

Fenwal

Lake Zurich, Illinois, United Stateskidde-fenwal.com ↗

Ownership: Private
Development stage: Other

Overview

Fenwal was a global leader in transfusion medicine technologies with commercialized products for automated and manual blood collection, separation, filtration, storage, and transfusion. Its innovations enabled safer and more efficient blood supply management worldwide. The company was acquired by Fresenius Kabi in 2012 to form a global leader in transfusion technology.[8][5][6]

Therapeutic areas: HematologyNeurologyOncologyOther
Modalities: DeviceBiologicCell therapy
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with hospitals/blood banks globallypartnerships with biotech/pharma companies for enabling cell therapy research/manufacturing

Beyond the preview

Go deeper on Fenwal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenwal.

Explore the full profile